SB
SBI Healthcare Opportunities Fund Direct Growth
Latest NAV
+20.19% 1Y
Sign In to Add to Portfolio
Benchmark: BSE Healthcare TRI
Expense ratio
1.04%
AUM
₹5,796 Cr
Min SIP
₹500
Min lump sum
₹5,000
1Y
+20.19%
3Y (ann.)
+22.83%
5Y (ann.)
+17.78%
Launched
Jan 2013
Where the NAV sits & how risky it is
₹584.62
52-week range
at 82%
₹584.62
Low 21 Jan 2026₹462.87
High 21 Sep 2026₹611.08
Risk level
Very High
Low
Very high
NAV history
03 Jan 2013
Since inception
01 Oct 2026
Returns by period
1W
-3.55%
1M
-3.34%
3M
+2.86%
6M
+22.10%
1Y
+20.19%
3Y
+22.83%
5Y
+17.78%
3Y and 5Y returns are annualised.
Return calculator
You invest
—
Est. gain
—
Est. value
—
Invested Gain
Invested
Projected value
min SIP ₹500
Estimate only. It assumes the selected past return repeats every year; 3Y and 5Y figures are taken as annualised. Actual returns vary and are not guaranteed.
Where your money goes
AS OF 31 MAY 2026
Equity 97.49%
Cash & other 2.57%
Sector split
Country split
Top 5 hold 33.9%
Top 10 hold 52.2%
35 equity holdings
Equity holdings
(top 30)
| # | Holding | Sector | Country | Weight | YTD |
|---|---|---|---|---|---|
| 1 | Sun Pharmaceutical
INE044A01036 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
11.03%
|
+6.50% |
| 2 | Divis Laboratories
INE361B01024 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
6.57%
|
+4.24% |
| 3 | Acutaas Chemicals
INE00FF01025 |
Basic Materials Specialty Chemicals |
India |
6.17%
|
+76.11% |
| 4 | Apollo Hospitals
INE437A01024 |
Healthcare Medical Care Facilities |
India |
5.37%
|
+19.81% |
| 5 | Max Healthcare Institute
INE027H01010 |
Healthcare Medical Care Facilities |
India |
4.76%
|
-1.81% |
| 6 | Aurobindo Pharma
INE406A01037 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
3.90%
|
+20.24% |
| 7 | Aster DM Healthcare
INE914M01019 |
Healthcare Medical Care Facilities |
India |
3.83%
|
+24.66% |
| 8 | Laurus Labs
INE947Q01028 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
3.58%
|
+23.74% |
| 9 | Biocon
INE376G01013 |
Healthcare Biotechnology |
India |
3.52%
|
+4.56% |
| 10 | Torrent Pharmaceuticals
INE685A01028 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
3.48%
|
+16.38% |
About this scheme
To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Fund manager(s): Tanmaya Desai
Exit load: Exit load of 0.50% if redeemed within 15 days
Scheme snapshot
VR Rating
MS Rating
Plan
Growth
Type
DIRECT
Inception
01 Jan 2013
Lump-sum min
₹5,000
SIP
Purchase
Switch
STP
SWP
Similar schemes
RANKED BY 1Y RETURN
Nippon India Taiwan Equity Fund Direct Growth
1▲ 101.4 pts ahead of this fund
Franklin Asian Equity Fund Direct Growth
2▲ 13.2 pts ahead of this fund
Nippon India Japan Equity Fund - Direct Plan - Growth Plan - Bonus Option
3▲ 10.4 pts ahead of this fund
Nippon India Japan Equity Fund Direct Growth
4▲ 10.4 pts ahead of this fund
Bank of India Small Cap Fund Direct Growth
5▲ 9.1 pts ahead of this fund
TRUSTMF Small Cap Fund Direct Growth
6▲ 8.9 pts ahead of this fund